Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 10404223)

1.

The GYF domain is a novel structural fold that is involved in lymphoid signaling through proline-rich sequences.

Freund C, Dötsch V, Nishizawa K, Reinherz EL, Wagner G.

Nat Struct Biol. 1999 Jul;6(7):656-60.

PMID:
10404223
2.

Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules.

Freund C, Kühne R, Yang H, Park S, Reinherz EL, Wagner G.

EMBO J. 2002 Nov 15;21(22):5985-95.

3.

Novel interaction partners of the CD2BP2-GYF domain.

Kofler M, Motzny K, Beyermann M, Freund C.

J Biol Chem. 2005 Sep 30;280(39):33397-402. Epub 2005 Jul 6.

4.

Alternative binding modes of proline-rich peptides binding to the GYF domain.

Gu W, Kofler M, Antes I, Freund C, Helms V.

Biochemistry. 2005 May 3;44(17):6404-15.

PMID:
15850374
5.

Recognition sequences for the GYF domain reveal a possible spliceosomal function of CD2BP2.

Kofler M, Heuer K, Zech T, Freund C.

J Biol Chem. 2004 Jul 2;279(27):28292-7. Epub 2004 Apr 22.

6.

GYF domain proteomics reveals interaction sites in known and novel target proteins.

Kofler M, Motzny K, Freund C.

Mol Cell Proteomics. 2005 Nov;4(11):1797-811. Epub 2005 Aug 23.

7.

Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation.

Nishizawa K, Freund C, Li J, Wagner G, Reinherz EL.

Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14897-902.

8.

Structural basis for the bifunctionality of the U5 snRNP 52K protein (CD2BP2).

Nielsen TK, Liu S, Lührmann R, Ficner R.

J Mol Biol. 2007 Jun 15;369(4):902-8. Epub 2007 Apr 4.

PMID:
17467737
9.

The SH3 domain of a M7 interacts with its C-terminal proline-rich region.

Wang Q, Deloia MA, Kang Y, Litchke C, Zhang N, Titus MA, Walters KJ.

Protein Sci. 2007 Feb;16(2):189-96. Epub 2006 Dec 22.

10.

Analysis of the CD2 and spliceosomal Sm B/B' polyproline-arginine motifs defined by a monoclonal antibody using a phage-displayed random peptide library.

Monos D, Heliopoulos J, Argyris E, Cordopatis P, Zompra A, Kamoun M.

J Mol Recognit. 2006 Nov-Dec;19(6):535-41.

PMID:
16941565
11.

The GYF domain.

Kofler MM, Freund C.

FEBS J. 2006 Jan;273(2):245-56. Review.

PMID:
16403013
12.

Identification of an expanded binding surface on the FADD death domain responsible for interaction with CD95/Fas.

Hill JM, Morisawa G, Kim T, Huang T, Wei Y, Wei Y, Werner MH.

J Biol Chem. 2004 Jan 9;279(2):1474-81. Epub 2003 Oct 22.

13.
14.

The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2.

Bell GM, Fargnoli J, Bolen JB, Kish L, Imboden JB.

J Exp Med. 1996 Jan 1;183(1):169-78.

15.
16.
17.

Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.

Dunne A, Ejdeback M, Ludidi PL, O'Neill LA, Gay NJ.

J Biol Chem. 2003 Oct 17;278(42):41443-51. Epub 2003 Jul 29.

18.

Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL.

Baum W, Kirkin V, Fernández SB, Pick R, Lettau M, Janssen O, Zörnig M.

J Biol Chem. 2005 Dec 2;280(48):40012-24. Epub 2005 Oct 4.

19.

Promiscuous binding nature of SH3 domains to their target proteins.

Agrawal V, Kishan KV.

Protein Pept Lett. 2002 Jun;9(3):185-93. Review.

PMID:
12144515
20.

Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.

Hake MJ, Choowongkomon K, Kostenko O, Carlin CR, Sönnichsen FD.

Biochemistry. 2008 Mar 11;47(10):3096-108. doi: 10.1021/bi701549a. Epub 2008 Feb 13.

PMID:
18269246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk